Amneal Gets FDA Green Light for Prednisolone Acetate Ophthalmic Suspension
A new option enters the American market for treating ocular inflammation. Amneal Pharmaceuticals (New Jersey, United States) announced on Thursday…
FDA Accepts NDA for Presbyopia Eye Drop BRIMOCHOL PF from Tenpoint Therapeutics
PDUFA date set for January 2026, launch expected first half of year The race to treat presbyopia just picked up…
latest posts
